| Literature DB >> 31361404 |
Paul Kruszka1, Tommy Hu1, Sungkook Hong1, Rebecca Signer2, Benjamin Cogné3, Betrand Isidor3, Sarah E Mazzola4, Jacques C Giltay5, Koen L I van Gassen5, Eleina M England6, Lynn Pais6, Charlotte W Ockeloen7, Pedro A Sanchez-Lara8,9, Esther Kinning10, Darius J Adams11, Kayla Treat12, Wilfredo Torres-Martinez12, Maria F Bedeschi13, Maria Iascone14, Stephanie Blaney15, Oliver Bell8, Tiong Y Tan16,17,18, Marie-Ange Delrue19, Julie Jurgens20, Brenda J Barry6,21, Elizabeth C Engle6,21,22, Sarah K Savage23, Nicole Fleischer23, Julian A Martinez-Agosto2, Kym Boycott24, Elaine H Zackai4, Maximilian Muenke1.
Abstract
Zinc finger protein 462 (ZNF462) is a relatively newly discovered vertebrate specific protein with known critical roles in embryonic development in animal models. Two case reports and a case series study have described the phenotype of 10 individuals with ZNF462 loss of function variants. Herein, we present 14 new individuals with loss of function variants to the previous studies to delineate the syndrome of loss of function in ZNF462. Collectively, these 24 individuals present with recurring phenotypes that define a multiple congenital anomaly syndrome. Most have some form of developmental delay (79%) and a minority has autism spectrum disorder (33%). Characteristic facial features include ptosis (83%), down slanting palpebral fissures (58%), exaggerated Cupid's bow/wide philtrum (54%), and arched eyebrows (50%). Metopic ridging or craniosynostosis was found in a third of study participants and feeding problems in half. Other phenotype characteristics include dysgenesis of the corpus callosum in 25% of individuals, hypotonia in half, and structural heart defects in 21%. Using facial analysis technology, a computer algorithm applying deep learning was able to accurately differentiate individuals with ZNF462 loss of function variants from individuals with Noonan syndrome and healthy controls. In summary, we describe a multiple congenital anomaly syndrome associated with haploinsufficiency of ZNF462 that has distinct clinical characteristics and facial features.Entities:
Keywords: zzm321990ZNF462; autism spectrum disorders; corpus callosum; craniosynostosis; developmental delay; ptosis
Mesh:
Substances:
Year: 2019 PMID: 31361404 PMCID: PMC6935050 DOI: 10.1002/ajmg.a.61306
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802